Intestinal lipid absorption in the nephrotic rat

William D. Paulson, Carlos N. Torres-Rivera, Laura Gray, Patrick Tso

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

There is limited data on intestinal lipid absorption in the nephrotic syndrome. This study investigated whether the efficiency of intestinal lipid absorption is altered in nephrotic lymph-fistula rats. The nephrotic syndrome was induced in nine Sprague-Dawley rats by an iv injection of puromycin aminonucleoside in saline; seven control rats received saline only. At 10 to 14 days after injection, the main intestinal lymph duct was cannulated for collection of lymph. The duodenum was also cannulated and a fasting saline-glucose solution was infused overnight at 3 mL/h, The next day, the infusate was changed to a lipid emulsion that contained (14C)cholesterol and (3H)triglyceride (triolein) that was infused at 3 mL/h for 8 h. During the last hour of tasting and during the lipid infusion, lymph flow in the Nephrotic group averaged 0.6 mL/h higher than the Control group (P = 0.02). No significant differences were found between the two groups in recovery of infused radioactive cholesterol (P = 0.37) or triglyceride (P = 0.38) from the gastrointestinal lumen, small intestinal mucosa, or lymph. Lymphatic output of chemically measured cholesterol was also similar (P = 0.96). These results suggest that mucosal uptake and lymphatic output of cholesterol and triglyceride are not altered in the nephrotic syndrome.

Original languageEnglish (US)
Pages (from-to)431-436
Number of pages6
JournalJournal of the American Society of Nephrology
Volume7
Issue number3
StatePublished - Mar 1 1996

Fingerprint

Intestinal Absorption
Lymph
Lipids
Nephrotic Syndrome
Cholesterol
Triglycerides
Puromycin Aminonucleoside
Triolein
Injections
Intestinal Mucosa
Emulsions
Duodenum
Sodium Chloride
Fistula
Sprague Dawley Rats
Fasting
Glucose
Control Groups

Keywords

  • Hypercholesterolemia
  • Hyperlipidemia
  • Hypertriglyceridemia
  • Puromycin aminonucleoside
  • Small intestine

ASJC Scopus subject areas

  • Nephrology

Cite this

Intestinal lipid absorption in the nephrotic rat. / Paulson, William D.; Torres-Rivera, Carlos N.; Gray, Laura; Tso, Patrick.

In: Journal of the American Society of Nephrology, Vol. 7, No. 3, 01.03.1996, p. 431-436.

Research output: Contribution to journalArticle

Paulson, WD, Torres-Rivera, CN, Gray, L & Tso, P 1996, 'Intestinal lipid absorption in the nephrotic rat', Journal of the American Society of Nephrology, vol. 7, no. 3, pp. 431-436.
Paulson, William D. ; Torres-Rivera, Carlos N. ; Gray, Laura ; Tso, Patrick. / Intestinal lipid absorption in the nephrotic rat. In: Journal of the American Society of Nephrology. 1996 ; Vol. 7, No. 3. pp. 431-436.
@article{6bc43410b4e74080b16560599804528e,
title = "Intestinal lipid absorption in the nephrotic rat",
abstract = "There is limited data on intestinal lipid absorption in the nephrotic syndrome. This study investigated whether the efficiency of intestinal lipid absorption is altered in nephrotic lymph-fistula rats. The nephrotic syndrome was induced in nine Sprague-Dawley rats by an iv injection of puromycin aminonucleoside in saline; seven control rats received saline only. At 10 to 14 days after injection, the main intestinal lymph duct was cannulated for collection of lymph. The duodenum was also cannulated and a fasting saline-glucose solution was infused overnight at 3 mL/h, The next day, the infusate was changed to a lipid emulsion that contained (14C)cholesterol and (3H)triglyceride (triolein) that was infused at 3 mL/h for 8 h. During the last hour of tasting and during the lipid infusion, lymph flow in the Nephrotic group averaged 0.6 mL/h higher than the Control group (P = 0.02). No significant differences were found between the two groups in recovery of infused radioactive cholesterol (P = 0.37) or triglyceride (P = 0.38) from the gastrointestinal lumen, small intestinal mucosa, or lymph. Lymphatic output of chemically measured cholesterol was also similar (P = 0.96). These results suggest that mucosal uptake and lymphatic output of cholesterol and triglyceride are not altered in the nephrotic syndrome.",
keywords = "Hypercholesterolemia, Hyperlipidemia, Hypertriglyceridemia, Puromycin aminonucleoside, Small intestine",
author = "Paulson, {William D.} and Torres-Rivera, {Carlos N.} and Laura Gray and Patrick Tso",
year = "1996",
month = "3",
day = "1",
language = "English (US)",
volume = "7",
pages = "431--436",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "3",

}

TY - JOUR

T1 - Intestinal lipid absorption in the nephrotic rat

AU - Paulson, William D.

AU - Torres-Rivera, Carlos N.

AU - Gray, Laura

AU - Tso, Patrick

PY - 1996/3/1

Y1 - 1996/3/1

N2 - There is limited data on intestinal lipid absorption in the nephrotic syndrome. This study investigated whether the efficiency of intestinal lipid absorption is altered in nephrotic lymph-fistula rats. The nephrotic syndrome was induced in nine Sprague-Dawley rats by an iv injection of puromycin aminonucleoside in saline; seven control rats received saline only. At 10 to 14 days after injection, the main intestinal lymph duct was cannulated for collection of lymph. The duodenum was also cannulated and a fasting saline-glucose solution was infused overnight at 3 mL/h, The next day, the infusate was changed to a lipid emulsion that contained (14C)cholesterol and (3H)triglyceride (triolein) that was infused at 3 mL/h for 8 h. During the last hour of tasting and during the lipid infusion, lymph flow in the Nephrotic group averaged 0.6 mL/h higher than the Control group (P = 0.02). No significant differences were found between the two groups in recovery of infused radioactive cholesterol (P = 0.37) or triglyceride (P = 0.38) from the gastrointestinal lumen, small intestinal mucosa, or lymph. Lymphatic output of chemically measured cholesterol was also similar (P = 0.96). These results suggest that mucosal uptake and lymphatic output of cholesterol and triglyceride are not altered in the nephrotic syndrome.

AB - There is limited data on intestinal lipid absorption in the nephrotic syndrome. This study investigated whether the efficiency of intestinal lipid absorption is altered in nephrotic lymph-fistula rats. The nephrotic syndrome was induced in nine Sprague-Dawley rats by an iv injection of puromycin aminonucleoside in saline; seven control rats received saline only. At 10 to 14 days after injection, the main intestinal lymph duct was cannulated for collection of lymph. The duodenum was also cannulated and a fasting saline-glucose solution was infused overnight at 3 mL/h, The next day, the infusate was changed to a lipid emulsion that contained (14C)cholesterol and (3H)triglyceride (triolein) that was infused at 3 mL/h for 8 h. During the last hour of tasting and during the lipid infusion, lymph flow in the Nephrotic group averaged 0.6 mL/h higher than the Control group (P = 0.02). No significant differences were found between the two groups in recovery of infused radioactive cholesterol (P = 0.37) or triglyceride (P = 0.38) from the gastrointestinal lumen, small intestinal mucosa, or lymph. Lymphatic output of chemically measured cholesterol was also similar (P = 0.96). These results suggest that mucosal uptake and lymphatic output of cholesterol and triglyceride are not altered in the nephrotic syndrome.

KW - Hypercholesterolemia

KW - Hyperlipidemia

KW - Hypertriglyceridemia

KW - Puromycin aminonucleoside

KW - Small intestine

UR - http://www.scopus.com/inward/record.url?scp=0029986553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029986553&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 431

EP - 436

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 3

ER -